Abstract
AbstractThe role of activity cliffs in drug discovery projects is certainly two‐edged: on the one hand, they often lead to the failure of QSAR modeling techniques; on the other, they are highly valuable for identifying key aspects of SARs. In the presence of activity cliffs the results of purely ligand‐based QSAR approaches often remain puzzling, and the resulting models have limited predictive power. Herein we present a new approach for the identification of structure‐based activity cliffs (ISAC). It uses the valuable information of activity cliffs in a structure‐based design scenario by analyzing interaction energies of protein–ligand complexes. Using the relative frequency at which a protein atom is involved in activity cliff events, we introduce a novel visualization of hot spots in the active site of a protein. The ISAC approach supports the medicinal chemist in elucidating the key interacting atoms of the binding site and facilitates the development of pharmacophore hypotheses. The hot spot visualization can be applied to small data sets in early project phases as well as in the lead optimization process. Based on the ISAC approach, we developed a method to derive target‐specific scoring functions and pharmacophore constraints, which were validated on independent external data sets in virtual screening experiments. The activity‐cliff‐based approach shows an improved enrichment over the generic empirical scoring function for various protein targets in the validation set.
References
31
Referenced
43
10.1021/ci060117s
10.1021/jm020155c
10.1021/ci100091e
10.1007/978-1-60761-839-3_3
10.1021/jm070845m
10.1021/jm0705713
10.1021/ci900243a
10.1021/ci7004093
10.1021/ci049870g
10.1021/jm030331x
10.1021/ci800466n
10.1021/ci900043r
10.1021/jm00014a020
10.1002/prot.22579
10.1021/jm990609e
10.1016/j.drudis.2009.03.013
10.1006/jmbi.1996.0477
10.1007/BF00126743
10.1021/jm801444x
10.1021/jm0608356
10.1016/S0960-894X(03)00302-0
10.1016/j.bmcl.2006.01.028
- Molecular Operating Environment (MOE) Chemical Computing Group Inc. Montreal QC (Canada).
{'key': 'e_1_2_6_24_2', 'first-page': '63', 'volume-title': 'Virtual Screening: An Alternative or Complement to High‐Throughput Screening', 'author': 'Rarey M.'}
/ Virtual Screening: An Alternative or Complement to High‐Throughput Screening by Rarey M.10.1016/S0021-9258(18)54894-8
10.1021/ja00066a004
10.1038/nature01370
{'key': 'e_1_2_6_28_2', 'first-page': '300', 'volume': '3', 'author': 'Rarey M.', 'year': '1995', 'journal-title': 'Proc. Int. Conf. Intell. Syst. Mol. Biol.'}
/ Proc. Int. Conf. Intell. Syst. Mol. Biol. by Rarey M. (1995)10.1006/jmbi.2001.5062
10.1021/ci049714
10.1023/A:1016399411208
Dates
Type | When |
---|---|
Created | 14 years, 1 month ago (July 12, 2011, 4:16 p.m.) |
Deposited | 1 year, 10 months ago (Oct. 10, 2023, 3:15 p.m.) |
Indexed | 3 months, 1 week ago (May 16, 2025, 9:34 p.m.) |
Issued | 14 years, 1 month ago (July 12, 2011) |
Published | 14 years, 1 month ago (July 12, 2011) |
Published Online | 14 years, 1 month ago (July 12, 2011) |
Published Print | 13 years, 11 months ago (Sept. 5, 2011) |
@article{Seebeck_2011, title={From Activity Cliffs to Target‐Specific Scoring Models and Pharmacophore Hypotheses}, volume={6}, ISSN={1860-7187}, url={http://dx.doi.org/10.1002/cmdc.201100179}, DOI={10.1002/cmdc.201100179}, number={9}, journal={ChemMedChem}, publisher={Wiley}, author={Seebeck, Birte and Wagener, Markus and Rarey, Matthias}, year={2011}, month=jul, pages={1630–1639} }